Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Tomoyuki, Nagata"'
Publikováno v:
Prion, Vol 16, Iss 1, Pp 7-13 (2022)
An 84-year-old woman who had been diagnosed as having dementia with Lewy body (DLB) upon initial examination exhibited cognitive impairments and person delusional misidentification (DMS): she transiently claimed that her spouse was a stranger. She wa
Externí odkaz:
https://doaj.org/article/9032d51623b1407498a49c79e7c801ab
Autor:
Hidemasa Kubo, Nobuki Yamaoka, Mizuki Tamai, Hajime Kamiya, Yosuke Kamada, Tomoyuki Nagata, Ken-ichiro Fukuda, Eigo Otsuji
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-5 (2019)
Abstract Background Polysplenia refers to the presence of two or more equal-sized spleens. Very rarely, one of the multiple spleens may develop torsion and infarction. Case presentation A 21-year-old woman presented with left upper quadrant pain, the
Externí odkaz:
https://doaj.org/article/52b446fbb9d8494a810710292826ee59
Autor:
Ayako Suzuki, Nobuto Shibata, Koji Kasanuki, Tomoyuki Nagata, Shunichiro Shinagawa, Nobuyuki Kobayashi, Tohru Ohnuma, Yoshihide Takeshita, Eri Kawai, Toshiki Takayama, Kenya Nishioka, Yumiko Motoi, Nobutaka Hattori, Kazuhiko Nakayama, Hisashi Yamada, Heii Arai
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 6, Iss 1, Pp 90-97 (2016)
Background/Aims: Mutations in the presenilin 2 (PSEN2) gene cause familial Alzheimer's disease (AD). Common polymorphisms affect gene activity and increase the risk of AD. Nonsynonymous polymorphisms in the PSEN2 gene showed Lewy body dementia (LBD)
Externí odkaz:
https://doaj.org/article/6442245d32674aca9f0f80089e02ac8a
Autor:
Keisuke Inamura, Shunichiro Shinagawa, Tomoyuki Nagata, Kenji Tagai, Kazutaka Nukariya, Masahiro Shigeta
Publikováno v:
Psychogeriatrics. 22:343-352
We examined differences in the severity of neuropsychiatric symptom (NPS) subsyndromes according to education level among patients with amnestic-mild cognitive impairment (a-MCI) with the aim of identifying patient demographics related to NPS subsynd
Autor:
Tomoyuki, Nagata, Shunichiro, Shinagawa, Nobuyuki, Kobayashi, Kazuhiro, Kondo, Masahiro, Shigeta
Publikováno v:
Prion, Vol 16, Iss 1, Pp 7-13 (2022)
An 84-year-old woman who had been diagnosed as having dementia with Lewy body (DLB) upon initial examination exhibited cognitive impairments and person delusional misidentification (DMS): she transiently claimed that her spouse was a stranger. She wa
Autor:
Tomoyuki Nagata, Nobuyuki Kobayashi, Jumpei Ishii, Shunichiro Shinagawa, Ritsuko Nakayama, Nobuto Shibata, Bolati Kuerban, Tohru Ohnuma, Kazuhiro Kondo, Heii Arai, Hisashi Yamada, Kazuhiko Nakayama
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 5, Iss 1, Pp 64-73 (2015)
Background/Aims: In the present study, we examined whether DNA methylation of the brain-derived neurotrophic factor (BDNF) promoter is associated with the manifestation and clinical presentation of Alzheimer's disease (AD). Methods: Of 20 patients wi
Externí odkaz:
https://doaj.org/article/bcba0903cbb54d52b808c08d8579e73d
Autor:
Kenji TAGAI1, Tomoyuki NAGATA1,2 t.nagata@jikei.ac.jp, Shunichiro SHINAGAWA1, Masahiro SHIGETA1
Publikováno v:
Psychogeriatrics. May2020, Vol. 20 Issue 3, p345-352. 8p.
Autor:
Tomoyuki Nagata, Azusa Ishii, Shunichiro Shinagawa, Naomi Oka, Kazuya Shimada, Masahiro Shigeta, Kenji Tagai, Kazuhiro Kondo, Nobuyuki Kobayashi
Publikováno v:
Journal of Alzheimer's Disease
Background: Behavioral and psychological symptoms of dementia (BPSD) cause a heavy burden for both patient and caregivers. These symptoms are diverse, and their mechanism is still unclear. Agitation is the most common and difficult to treat among BPS
Publikováno v:
Expert opinion on pharmacotherapy. 23(6)
Alzheimer's disease (AD) is the most common form of dementia, and four medications are currently available as symptomatic therapies: three cholinesterase inhibitors (ChEI) and memantine. In June 2021, aducanumab was approved in the United States unde
Autor:
Tomoyuki Nagata, Nobuto Shibata, Shunichiro Shinagawa, Ritsuko Nakayama, Bolati Kuerban, Tohru Ohnuma, Heii Arai, Kazuhiko Nakayama, Hisashi Yamada
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 3, Iss 1, Pp 272-280 (2013)
Background: Some polymorphisms of the neurotrophin family have previously been investigated as candidate genes for Alzheimer's disease (AD). In the present study, we examined whether neurotrophin-3 (NTF-3) polymorphisms are genetic risk factors in pa
Externí odkaz:
https://doaj.org/article/c67bb0cf6aab44a39790874fd91665f5